The efficacy of tretinoin gel 0.1% followed by topical minoxidil-5% in individuals with androgenetic alopecia
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252067Keywords:
Androgenetic alopecia, Minoxidil, Tretinoin, Hair growth, Combination therapyAbstract
Androgenetic alopecia (AGA) is a progressive hair loss condition, with a higher prevalence among males aged 30-50 years in the Indian population. Minoxidil, a topical treatment, is commonly used but shows variable efficacy, particularly in non-responders. Recent studies suggest that combining minoxidil with tretinoin may enhance its effectiveness by increasing scalp absorption and improving hair follicle activity. This case series included 20 patients with AGA (male Norwood-Hamilton grades II-V and female Ludwig grades I-II), clinically diagnosed as non-responders to minoxidil. Participants received a combination therapy of 0.1% tretinoin gel and 5% minoxidil solution over 90 days. Improvements were observed in trichoscopic parameters where 32.9% increase in hair count and density, 3.5% rise in anagen-phase hairs, and 4.8% increase in hair thickness. Investigator global photography assessments revealed 20% of participants showed 51-75% improvement. Advanced AGA grades showed partial reversal. Patient self-assessments indicated 50% improvement in hair quality, 70% in hair coverage, and 75% in overall appearance. Most participants reported new hair growth (80%) and satisfaction with treatment. The combination of 0.1% tretinoin gel and 5% minoxidil demonstrated efficacy in improving hair growth and patient satisfaction in AGA patients who are non- responder to minoxidil.
Metrics
References
Shankar DK, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: Population-based study in 1,005 subjects. Int J Trichol. 2009;1:131-3. DOI: https://doi.org/10.4103/0974-7753.58556
Mantovani GP, Marra C, De Maria F, Pinto V, De Santis G. Adipose-derived stromal vascular fraction (SVF) for the treatment of androgenic alopecia (AGA): a systematic review. Acta Biomed. 2023;94(5):e2023236.
Shadi, Z. Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia. Dermatol Ther (Heidelb). 2023;13:1157-69. DOI: https://doi.org/10.1007/s13555-023-00919-x
Dhurat R, Daruwalla S, Pai S. SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth. J Cosmet Dermatol. 2021;00:1-4. DOI: https://doi.org/10.1111/jocd.14299
Goren A, Castano JA, McCoy J, Bermudez F, Lotti T. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. Dermatol Therap. 2013;27(3):171-3. DOI: https://doi.org/10.1111/dth.12111
Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-86. DOI: https://doi.org/10.2147/DDDT.S214907
Sharma A, Goren A, Dhurat R, Agrawal S, Sinclair R, Trüeb RM, et al. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatol Ther. 2019;32(3):e12915. DOI: https://doi.org/10.1111/dth.12915
Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol. 2007;8(5):285-90. DOI: https://doi.org/10.2165/00128071-200708050-00003
Zarkesh K, Khazaeli P, Pardakhty Abbas and Rezaifar M. Preparation and Physicochemical Characterization of Topical Niosomal Formulation of Minoxidil and Tretinoin. Global J Pharmacy Pharmaceut Sci. 2017;3(2):21-6. DOI: https://doi.org/10.19080/GJPPS.2017.03.555606
Voorhees JJ. Clinical effects of long-term therapy with topical tretinoin and cellular mode of action. J Int Med Res. 1990;18:26-8.
Ferry JJ, Forbes KK, VanderLugt JT, Szpunar GJ. Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clin Pharmacol Therapeut. 1990;47:439-46. DOI: https://doi.org/10.1038/clpt.1990.55
Kwon OS, Pyo HK, Oh YJ, Han JH, Lee SR, Chung JH, et al. Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro. J Korean Med Sci. 2007;22(2):283-9. DOI: https://doi.org/10.3346/jkms.2007.22.2.283
Yoo HG, Chang IY, Pyo HK, Kang YJ, Lee SH, Kwon OS, Cho KH, Eun HC, Kim KH. The additive effects of minoxidil and retinol on human hair growth in vitro. Biol Pharm Bull. 2007;30(1):21-6. DOI: https://doi.org/10.1248/bpb.30.21
Pratiksha K, Nayak K, Thakkar S, Polaka S, Khunt D, Misra M. Exploring the Potential of Minoxidil Tretinoin Liposomal Based Hydrogel for Topical Delivery in the Treatment of Androgenic Alopecia. Cutaneous Ocular Toxicol. 2020;39(1):43-53. DOI: https://doi.org/10.1080/15569527.2019.1694032